Reduced postprandial bone resorption and greater rise in GLP-1 in overweight and obese individuals after an α-glucosidase inhibitor: a double-blinded randomized crossover trial

ConclusionThis study indicates that attenuating postprandial glycemic indices, with an α-GI, markedly decreases postprandial bone resorption and can be explained by the rise in GLP-1. Future studies should determine whether longer term α-GI use benefits bone health.

http://link.springer.com/10.1007/s00198-020-05791-5

Source: Osteoporosis International - January 11, 2021 Category: Orthopaedics Source Type: research